TrialNutrition, metabolism, and cardiovascular diseases : NMCD2020

Liraglutide decreases energy expenditure and does not affect the fat fraction of supraclavicular brown adipose tissue in patients with type 2 diabetes.

Huub J van Eyk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.